Hayato Kawachi   Tadaaki Yamada   Motohiro Tamiya   Yoshiki Negi   Yasuhiro Goto   Akira Nakao   Shinsuke Shiotsu   Keiko Tanimura   Takayuki Takeda   Asuka Okada   Taishi Harada   Koji Date   Yusuke Chihara   Isao Hasegawa   Nobuyo Tamiya   Masaki Ishida   Yuki Katayama   Kenji Morimoto   Masahiro Iwasaku   Shinsaku Tokuda   Takashi Kijima   Koichi Takayama   
JAMA network open 6(7) e2322915 2023年7月 [査読有り]
IMPORTANCE: Immune checkpoint inhibitor (ICI) monotherapy with pembrolizumab and ICI plus chemotherapy have been approved as first-line treatments for non-small cell lung cancer (NSCLC) for patients with a programmed cell death ligand-1 (PD-L1) tu...